EPIMS
MBOT icon

Evelyn Partners Investment Management Services’s Microbot Medical MBOT Stock Holding History

Evelyn Partners Investment Management Services’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2 Hold
1
– – ﹤0.01% 280
2025
Q4 		$2 Hold
1
– – ﹤0.01% 261
2025
Q3 		$3 Hold
1
– – ﹤0.01% 266
2025
Q2 		$3 Hold
1
– – ﹤0.01% 264
2025
Q1 		$2 Hold
1
– – ﹤0.01% 271
2024
Q4 		$1 Buy
+1
New +$1 ﹤0.01% 277

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Evelyn Partners Investment Management Services's MBOT Position: Q1 2026 in Review

Evelyn Partners Investment Management Services held its Microbot Medical (MBOT) position steady in Q1 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #280.

Evelyn Partners Investment Management Services first reported a position in MBOT in Q4 2024 and has held it in 6 quarters since. The position peaked at $3 in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Evelyn Partners Investment Management Services held 1 share of Microbot Medical worth $2 as of Q1 2026.
  • Evelyn Partners Investment Management Services left its Microbot Medical share count unchanged in Q1 2026.
  • Microbot Medical made up ﹤0.01% of Evelyn Partners Investment Management Services's portfolio in Q1 2026, its #280 holding.
  • Evelyn Partners Investment Management Services first reported a position in Microbot Medical in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management Services's Microbot Medical position peaked at $3 in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Evelyn Partners Investment Management Services's 13F filing for Q1 2026, filed 15 May 2026.